CD8A and small cell lung carcinoma: In SCLC-A, the most common type of SCLC, the CD8-high group was associated with favorable PFS (P = 0.025) (Fig. S2A) and OS (P = 0.010) (Fig. S2C) in the chemoimmunotherapy cohort.